Title: Michael Poslusney: Innovator in Pharmaceutical Chemistry
Introduction: Michael Poslusney is an accomplished inventor based in Baltimore, MD (US). He is currently associated with the Lieber Institute, Inc. Despite having no granted patents to his name, his contributions to the field of pharmaceutical chemistry are noteworthy. His work focuses on developing innovative chemical entities that have the potential to impact systemic diseases.
Latest Patent Applications: Michael Poslusney's latest patent application is titled "Substituted Benzopyrazolo[1,5-a][1,4]Diazepines as GABA Positive Allosteric Modulators." This disclosure features chemical entities that act as positive allosteric modulators of GABA-A receptors. These compounds are designed to selectively target the peripheral nervous system and organs of the body, without substantially passing through the blood-brain barrier. The application highlights the potential use of these compounds in treating systemic diseases where modulation of GABA-A receptors is beneficial.
Conclusion: Michael Poslusney's innovative work at the Lieber Institute, Inc. showcases his commitment to advancing pharmaceutical chemistry. His research on GABA positive allosteric modulators holds promise for future therapeutic applications.